Ann Burchell


Scientist, Li Ka Shing Knowledge Institute


Ann Burchell is an epidemiologist and Scientist with the Department of Family and Community Medicine and Li Ka Shing Knowledge Institute at St. Michael’s Hospital, Toronto. She holds degrees in epidemiology from the University of Toronto (MSc) and McGill University (PhD) and has academic appointments as Assistant Professor, Dalla Lana School of Public Health, University of Toronto; Adjunct Professor, Division of Cancer Epidemiology, McGill University; and Adjunct Scientist, Institute for Clinical Evaluative Medicine, Toronto.

Dr. Burchell’s research program focuses on the epidemiology of human immunodeficiency virus (HIV) infection, human papillomavirus (HPV), syphilis, and other sexually transmitted infections (STIs). She has a particular interest in generating evidence for effective, efficient, and practical primary and secondary prevention strategies for control of STIs and STI-related cancers in marginalized communities.

She has extensive methodological experience in the design and implementation of: observational longitudinal studies with primary and secondary data; sexual behavior and health-access questionnaires; natural history studies using laboratory markers of infection; and, most recently, pragmatic randomized trials for HPV prevention and improved screening for syphilis, cervical and anal cancer. She currently holds a New Investigator award from the Canadian Institutes of Health Research.

Recent Publications

  1. de Pokomandy, A, Kaufman, E, de Castro, C, Mayrand, MH, Burchell, AN, Klein, M et al.. The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV. J. Infect. Dis. 2017;216 (4):447-456. doi: 10.1093/infdis/jix273. PubMed PMID:28931234 .
  2. Kendall, CE, Walmsley, S, Lau, C, Jembere, N, Burchell, AN, Loutfy, M et al.. A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada. CMAJ Open. 2017;5 (3):E673-E681. doi: 10.9778/cmajo.20170038. PubMed PMID:28855308 .
  3. Jeon, C, Lau, C, Kendall, CE, Burchell, AN, Bayoumi, AM, Loutfy, M et al.. Mortality and Health Service Use Following Acute Myocardial Infarction Among Persons with HIV: A Population-Based Study. AIDS Res. Hum. Retroviruses. 2017; :. doi: 10.1089/AID.2017.0128. PubMed PMID:28817947 .
  4. Szadkowski, L, Walmsley, S, Burchell, AN, Collins, E, Rourke, SB, Raboud, J et al.. High retention in HIV care at a tertiary care centre in Toronto, Canada. AIDS Care. 2017; :1-9. doi: 10.1080/09540121.2017.1349278. PubMed PMID:28678619 .
  5. Wheeler, KM, Antoniou, T, Gardner, S, Light, L, Grewal, R, Globerman, J et al.. Sociodemographic and Health Profile of Heterosexual Men Living With HIV in Ontario, Canada. Am J Mens Health. 2017;11 (4):855-862. doi: 10.1177/1557988317696639. PubMed PMID:28625119 .
  6. Benoit, AC, Younger, J, Beaver, K, Jackson, R, Loutfy, M, Masching, R et al.. Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada. Can J Public Health. 2017;108 (2):e169-e175. . PubMed PMID:28621653 .
  7. OʼNeill, TJ, Nguemo, JD, Tynan, AM, Burchell, AN, Antoniou, T. Risk of Colorectal Cancer and Associated Mortality in HIV: A Systematic Review and Meta-Analysis. J. Acquir. Immune Defic. Syndr. 2017;75 (4):439-447. doi: 10.1097/QAI.0000000000001433. PubMed PMID:28471838 PubMed Central PMC5483984.
  8. Patterson, S, Jose, S, Samji, H, Cescon, A, Ding, E, Zhu, J et al.. A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada. HIV Med. 2017;18 (9):655-666. doi: 10.1111/hiv.12505. PubMed PMID:28440036 .
  9. Antoniou, T, Szadkowski, L, Walmsley, S, Cooper, C, Burchell, AN, Bayoumi, AM et al.. Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients. BMC Infect. Dis. 2017;17 (1):266. doi: 10.1186/s12879-017-2379-8. PubMed PMID:28399819 PubMed Central PMC5387339.
  10. Rossi, C, Raboud, J, Walmsley, S, Cooper, C, Antoniou, T, Burchell, AN et al.. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy. BMC Infect. Dis. 2017;17 (1):246. doi: 10.1186/s12879-017-2350-8. PubMed PMID:28376824 PubMed Central PMC5381089.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, University of Toronto, Dalla Lana School of Public Health